Interestingly, TET2 is considered as a tumor suppressor gene and its enzymatic activity is inhibited in IDH-mutated tumors by the accumulation of 2-HG; this is further connected with the low levels of 5-methylcytosine oxidation that sustains cancer development, including prostate [44]. Here, IDH1 is linked to neoplasm.